Purchases and Sales Made in Q2 2024 in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX) during Q2 2024. The information is specifically focused on institutions that hold shares of EAGLE PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 06, 2024
Q2 2024
|
Lsv Asset Management
Chicago, IL |
SELL
|
- |
-38.8K- 11.6% |
$129K - $217K
|
295K
$177K
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-48.8K- 22.2% |
$163K - $273K
|
171K
$103K
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-56.3K- 96.05% |
$188K - $315K
|
2.32K
$1.39K
|
|
Aug 05, 2024
Q2 2024
|
Los Angeles Capital Management LLC
|
SELL
|
- |
-59.1K- 30.84% |
$197K - $331K
|
133K
$79.6K
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-62K- 24.08% |
$207K - $347K
|
195K
$117K
|
|
Aug 14, 2024
Q2 2024
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-67.6K- 26.13% |
$226K - $378K
|
191K
$115K
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-74.9K- 19.95% |
$250K - $419K
|
300K
$180K
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-74.9K- 19.95% |
$250K - $419K
|
300K
$180K
|
|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-76.4K- 11.92% |
$255K - $428K
|
564K
$339K
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-89.6K- 26.84% |
$299K - $502K
|
244K
$147K
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-90.1K- 34.93% |
$301K - $504K
|
168K
$101K
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-98.7K- 55.52% |
$330K - $553K
|
79.1K
$47.5K
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-124K- 53.37% |
$413K - $692K
|
108K
$64.8K
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-178K- 83.24% |
$594K - $996K
|
35.8K
$21.5K
|
|
Aug 14, 2024
Q2 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-182K- 20.74% |
$609K - $1.02M
|
697K
$418K
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-545K- 60.71% |
$1.82M - $3.05M
|
353K
$212K
|